3.14
Bölmeli Modeller: İki Bölmeli Model
İki bölmeli model, organlar ve dokular arasında değişen kan perfüzyon oranlarını hesaba katarak ilaç dağılımını etkileyen vücudu merkezi ve periferik…
İki bölmeli model, kan perfüzyon hızı farklı organlar ve dokular arasında değiştiği için ilaçların vücuda eşit olarak dağılmadığını varsayar. Böylece, bu model vücudu merkezi ve periferik bölmelere ayırır.
Merkezi bölme, ilacın hızla dağıtıldığı kan ve yüksek derecede perfüze edilmiş dokulardan oluşur.
Periferik kompartman, ilaç dağılımının yavaş olduğu dokulardan oluşur.
Tek bir IV bolus dozunu takiben, ilaç konsantrasyonu plazmada yüksek ve dokularda düşüktür.
İlacın bölmeler arasındaki dağılımı, transfer sabiti veya mikro sabit olarak adlandırılan hız sabitleri tarafından tanımlanan birinci dereceden bir işlemdir.
Dağılım nedeniyle, ilaç konsantrasyonu plazmada hızla azalır ve bir dengeye ulaşılana kadar dokularda artar.
Bundan sonra, eliminasyon nedeniyle her iki bölmede de ilaç konsantrasyonu yavaş yavaş azalır.
Kısacası, plazma ilaç konsantrasyonu iki üstel olarak azalır, burada hızlı ilk düşüş dağılım veya ɑ fazıdır ve sonraki düşüş eliminasyon veya β fazıdır.
View the full transcript and gain access to JoVE Core videos
Q1: Why does the two-compartment model divide the body into central and peripheral compartments?
The two-compartment model accounts for varying blood perfusion rates among organs and tissues. The central compartment includes blood and highly perfused tissues where drugs distribute rapidly, while the peripheral compartment contains tissues with slower drug distribution. This division reflects the reality that drug distribution is not uniform throughout the body.
Q2: What happens to drug concentration immediately after an IV bolus dose?
Following a single IV bolus dose, drug concentration is initially high in plasma and low in tissues. The drug concentration rapidly declines in plasma while simultaneously increasing in tissues as distribution occurs. This rapid initial decline represents the distribution or alpha phase of plasma concentration change.
Q3: How does drug distribution between compartments follow first-order kinetics?
Drug distribution between the central and peripheral compartments is a first-order process defined by rate constants termed transfer constants or micro constants. These constants govern how quickly drug molecules move from highly perfused tissues to slower-perfused tissues, controlling the rate and extent of drug redistribution throughout the body.
Q4: What occurs when drug concentration reaches equilibrium between compartments?
Once equilibrium is reached between central and peripheral compartments, drug concentration stops changing due to distribution. After this point, both compartments experience a slow, simultaneous decline in drug concentration due to elimination processes. This slower phase is called the elimination or beta phase.
Q5: Why does plasma drug concentration decline bi-exponentially in the two-compartment model?
Plasma drug concentration declines bi-exponentially because two distinct processes occur sequentially. The rapid initial decline represents the distribution or alpha phase as drug moves from plasma to tissues. The subsequent slower decline represents the elimination or beta phase after equilibrium is established and drug is removed from both compartments.
Q6: How does the two-compartment model differ from assuming uniform drug distribution?
The two-compartment model recognizes that blood perfusion rates vary among different organs and tissues, preventing uniform drug distribution. By dividing the body into central and peripheral compartments with different distribution rates, the model accurately predicts how drug concentration changes over time in plasma and tissues, rather than assuming instantaneous equilibrium.
Q7: What is the relationship between transfer constants and drug movement in compartmental analysis?
Transfer constants, also called micro constants, quantify the rate of drug movement between central and peripheral compartments during the first-order distribution process. These constants determine how quickly drug redistributes from highly perfused tissues to slower-perfused tissues and influence the duration and shape of the distribution phase in plasma concentration profiles.